
Rolf Wachter
@rowachter
ID: 476163241
27-01-2012 20:55:36
21 Tweet
53 Followers
60 Following


+++ News-Update am Freitag +++: Frankreich erklärt Paris wieder zu Risikogebiet spiegel.de/wissenschaft/c… via DER SPIEGEL


Dear #Cardiotwitter check out our recent paper in #EJHF, where we identified a distinct protein profile in obese HFpEF patients , which was characterized by biomarkers of volume expansion, fibrosis and inflammation Philipp Lurz Holger Thiele Karl-Philipp Rommel onlinelibrary.wiley.com/doi/10.1002/ej…


40% pts getting AF ablation would consider sham trial...in Europe. Would % change in US/Canada? Would >40% #Epeeps consider it? Jonathan Piccini, MD, MHS Jason Andrade "Patients' attitude towards a sham-controlled trial on PVI in AF" pubmed.ncbi.nlm.nih.gov/34709451/

Happy to announce first patient randomised into PVI-SHAM-AF at Universitätsklinikum Leipzig (NCT05119231). This trial will evaluate the effect of pulmonary vein ablation on quality of life in comparison to a sham procedure. Great collaboration with @nikdagres Gerhard Hindricks Tobias Uhe


.John Mandrola, MD — My picks for AF trials ✳️LAAO vs no therapy in high bleeding risk, LAAO vs. 1/2 dose DOAC in others ✳️Sham PVI ablation trial ✳️In older pts - AF ablation vs AVJ/conduction system pacing ✳️DOAC vs placebo in SCAF > 6hrs #wafib2022


Happy to announce 10% of patients randomised into PVI-sham-AF (NCT05119231) within eight months in only two active study centers (three more to open soon). Great collaboration with @nikdagres, Gerhard Hindricks, Sergio Richter, Thomas Gaspar, Sonia Busch, Lars Eckardt, Tobias Uhe


👋Welcome to new #PHRI Research Fellow Tina Stegmann! Supervised by PHRI Scientist David Conen, Tina will focus on prevalence & distribution pattern of vascular brain lesions and correlating #cognitivefunction in patients with #AFib compared to patients with high #CVD burden.


Some argued a sham-controlled trial would be impossible. Happy to announce that the team of Mathias Forkmann today randomized patient #100 into the PVI-sham-AF trial (NCT05119231). Great collaboration with @nikdagres Gerhard Hindricks Sergio Richter Thomas Gaspar BorislavDinov

Great project ideas and excellent discussions at the “Clinical Trialists of Tomorrow” workshop of Universitätsklinikum Leipzig, organized by Rolf Wachter and the team of ZKS Leipzig. Glad to see the next generation of researchers and to be able to contribute.



Baseline characteristics of TransitionCHF DZHK2 presented by Irina Müller-Kozarez from University Hospital Leipzig in colllaboration with Anja Sandek und Gerd Hasenfuß Strom University Medicine Göttingen at DGK 2024. Deutsche Gesellschaft für Kardiologie DZHK Germany Universitätsklinikum Leipzig Universitätsmedizin Göttingen (UMG)

🌟 Spannende Einblicke vom Leipziger Kardiologengespräch 2024! 🌟 #ACC.24 Kongress-Update im Livestream: webucation.online/herzmedizin/ Mittwoch 10.04. 19:00 h Herzmedizin.de Deutsche Gesellschaft für Kardiologie AGIK Janine Pöss Young DGK AGEP



Happy to announce patient #5000 randomised into #Find-AF2 today. Only 200 more to go. Primary results will be presented in 2026. Will answer the question whether enhanced, prolonged and intensified heart rhythm monitoring leads to a reduction in recurrent stroke risk. UNIVERSITÄT LEIPZIG


Patient 5,200 was just randomised into #find-af2. find-af2.com. Thanks to 51 great study sites, numerous study coordinators and investigators and > 5,400 patients having given informed consent. Thanks at DFG public | @[email protected] for funding. UNIVERSITÄT LEIPZIG Universitätsmedizin Mainz
